Detalhe da pesquisa
1.
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis.
Blood
; 132(16): 1664-1674, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185431
2.
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.
Am J Hematol
; 93(2): 277-285, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29134664